These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine. Howell G, West L, Jenkins C, Lineberry B, Yokum D, Rockhold R. BMC Pharmacol; 2005 Aug 18; 5():13. PubMed ID: 16109168 [Abstract] [Full Text] [Related]
4. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Ogren SO, Carlsson S, Bartfai T. Psychopharmacology (Berl); 1985 Aug 18; 86(3):258-64. PubMed ID: 3929296 [Abstract] [Full Text] [Related]
19. Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones. Amstutz R, Ringdahl B, Karlén B, Roch M, Jenden DJ. J Med Chem; 1985 Dec 15; 28(12):1760-5. PubMed ID: 2933518 [Abstract] [Full Text] [Related]
20. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies. Engström C, Undén A, Ladinsky H, Consolo S, Bartfai T. Psychopharmacology (Berl); 1987 Dec 15; 91(2):161-7. PubMed ID: 3107028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]